Agios Pharmaceuticals
AGIO
#5052
Rank
C$2.23 B
Marketcap
C$38.31
Share price
1.13%
Change (1 day)
-56.07%
Change (1 year)

Agios Pharmaceuticals (AGIO) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$0.14 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's total liabilities are C$0.14 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Agios Pharmaceuticals - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$0.17 B4.88%
2023-12-31C$0.16 B-10.62%
2022-12-31C$0.18 B0.73%
2021-12-31C$0.18 B-67.87%
2020-12-31C$0.57 B76.93%
2019-12-31C$0.32 B40.36%
2018-12-31C$0.23 B-22.48%
2017-12-31C$0.30 B-14.2%
2016-12-31C$0.35 B236.72%
2015-12-31C$0.10 B32.65%
2014-12-31C$78.37 M5.6%
2013-12-31C$74.22 M-19.84%
2012-12-31C$92.58 M-30.69%
2011-12-31C$0.13 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Xencor
XNCR
C$0.33 B 140.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$0.91 B 553.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$159.74 B 113,966.58%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$2.15 B 1,437.03%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$84.66 B 60,353.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Eli Lilly
LLY
C$125.83 B 89,749.17%๐Ÿ‡บ๐Ÿ‡ธ USA